Using a dynamic susceptibility contrast (DSC) MRI DRO we previously characterized brain tumor relative cerebral blood volume (rCBV) reproducibility across 12 sites employing a range of imaging protocols and software platforms. Our goal in this study is to determine the impact of rCBV reproducibility for tumor grade classification. We found that varying software platforms produced a range of optimal thresholds, but the performance of these thresholds were similar. These results indicate that different software platforms are able to classify tumor grades, but the site-specific thresholds underscore the importance of standardizing acquisition and analysis protocols across sites and software benchmarking.
This abstract and the presentation materials are available to members only; a login is required.